Fundraising FoxRegeneron Ventures
Corporate VCGreenwich · Seed
Also known as POSITIVE SELECTION INVESTMENT MANAGEMENT, LLC · Regeneron
Find your way into Regeneron Ventures
Sign up to see every warm intro you have to Regeneron Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Regeneron Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Regeneron Ventures invests in health care broadly, with particular emphasis on biotechnology, devices, tools, and enabling technologies. It bases investment decisions on the quality of people, science, and data, favoring breakthrough innovation while tolerating risk and uncertainty. Backed solely by Regeneron Pharmaceuticals as its single and exclusive limited partner, the fund shares a patient-centric, science-based mission. It views companies as idiosyncratic and supports each in following its own path, aiming to help portfolio companies turn great ideas into great products that benefit patients.
Source: firm website, verified Oct 13, 2026.
What they invest in
from 7 of 8 portfolio companiesBiotech ×7Medical Devices ×4Healthtech ×3AI & Machine Learning ×2Deep Tech ×1Longevity ×1
HQs:United States×5
Investments · 8 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 42024 · 12021 · 18 dated
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)
Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsLuma GroupOUP (Osage University Partners)SoftBank Vision Fund+4 more
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin Capital+5 more
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsFinchley Healthcare VenturesLongwood FundLuma GroupSofinnova VenturesBAM ElevateForbion+2 more
Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
Co-investorsCancer FocusInvest-NL
Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance.
BiotechHealthtech
Rachel Humphrey(Founding Chief Executive Officer)inLieping Chen(Scientific Founder)Mitchell Keegan(Chief Development Officer)inWilliam LaRochelle(Chief Scientific Officer)inStacy M. Plum(Chief Technology Officer)
Co-investorsSanofi VenturesTaiho Ventures, LLCPfizer VenturesSamsara BioCapitalCanaan PartnersConnecticut Innovations+6 more
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Tasuku Kitada(Executive Officer, Director, Promoter)inJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)in
BoardJeb Keiper(Director)inAla Alenazi(Director)inPegah Ebrahimi(Director)in
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalAmgen VenturesANRIFPV+3 more
Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases.
AI & Machine LearningBiotechMedical DevicesBoston, US
Jacob Becraft(CEO, Co-Founder)inTasuku Kitada(President, Head of R&D, Co-founder)inRon Weiss(Scientific Co-founder)inDarrell J. Irvine(Scientific Co-founder)inPrashant Nambiar(Chief Scientific Officer)Ethan Cash(Senior Vice President, Head of Portfolio Management and Program Development)in
Co-investorsAtinum Investment Co. Ltd.FPVLG Technology VenturesPlayground GlobalPotentum PartnersAlix Ventures+5 more
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Co-Founder, President, CFO, COO)inDerek Jantz(Executive Officer)inCharles Gersbach(Co-Founder)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Co-Founder, Investor)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersHatteras Venture PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalRV Invest GmbH+2 more
Portfolio news
latest coverage across their companiesCity Therapeutics · finsmes.com · Jun 9, 2026
Coultreon · coultreon.com · Apr 28, 2026
Frequently asked questions
- How many investments has Regeneron Ventures made?
- Regeneron Ventures has 8 tracked investments, including 6 dated in the last 24 months.
- What stage does Regeneron Ventures invest at?
- Regeneron Ventures invests at the Seed stage.
- What sectors does Regeneron Ventures focus on?
- Regeneron Ventures focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Regeneron Ventures located?
- Regeneron Ventures is headquartered in Greenwich, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.